Skip to content
Screener

Repligen RGEN Total Current Liabilities

Total Current Liabilities at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$15.07B+18.5%
Danaher logo
DanaherDHR
$8.11B+19.3%
Maravai LifeSciences Holdings, Inc. logo
Maravai LifeSciences Holdings, Inc.MRVI
$42.62M-32.5%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$917M+81.0%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$1.13B+5.0%
TEC
Bio-TechneTECH
$153.28M-9.4%

Other financials

Income statement

See full
Revenue$204.1M+11.9%
Gross profit$110.0M+20.7%
Operating income$14.0M+0.6%
Net income$5.0M-66.3%
EPS (diluted)$0.09-65.4%

Balance sheet

See full
Cash & equivalents$606.8M-14.4%
Total debt$690.9M+354%
Total equity$2.1B+2.4%
Total assets$3.0B+1.7%

Cash flow

See full
Operating cash flow$32.8M+14.5%
CapEx$5.3M-24.9%
Free cash flow$27.4M+27.5%

Valuation

See full
Market cap$8.95B+42.1%
Enterprise value$9.03B+57.3%
P/E215.5×
P/S11.6×+0.3×

Profitability

See full
Gross margin47.6%+0.9pp
Operating margin15.6%-11.0pp
Net margin17.3%-3.5pp
FCF margin22%+6.9pp

Returns & leverage

See full
Return on equity2%+1.6pp
Debt / equity0.3×+0.3×
Current ratio9.1×+0.5×

Where this comes from

Reported directly by Repligen in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The source filing: Repligen’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:19 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-323773
Line itemJune 30, 2026December 31, 2025
Operating lease liabilities19,31821,559
Contingent consideration3,0255,049
Accrued liabilities77,08079,208
Total current liabilities132,656135,826
Convertible Senior Notes due 2028, net551,046542,213
Deferred tax liabilities16,77822,496
Noncurrent operating lease liabilities120,578126,176
Noncurrent contingent consideration1,304

ITEM 1. Financial Statements

FAQ

What is Repligen's total current liabilities?
Repligen (RGEN) reported total current liabilities of $132.66M in Q2 2026.
How has Repligen's total current liabilities changed year-over-year?
Repligen's total current liabilities increased by 7.8% year-over-year, from $123.01M to $132.66M.
What is the long-term trend for Repligen's total current liabilities?
Over 5 years (2020 to 2025), Repligen's total current liabilities has grown at a -15.7% compound annual growth rate (CAGR), from $318.96M to $135.83M.
What does total current liabilities mean?
The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.

Ask your AI about Repligen's total current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude